About: covid:PMC7445375

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7445375 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Berlot, Giorgio Amato, Paola Bianco, Francesco Chiella, Fabrizio Gerini, Ugo La Fata, Cristina Piva, Marco Randino, Anna Roman Pognuz, Erik Tomasini, Ariella Tomietto, Paola Trenti, Tommaso di Maso, Vittorio
is schema:about of	named entity 'Case' named entity 'Pneumonia' named entity 'Tocilizumab' named entity 'Pneumonia' named entity 'SARS-COV-2' named entity 'Italy' named entity 'Monmouth Junction' named entity 'sepsis' named entity 'chimeric antibody' named entity 'rheumatoid arthritis' named entity 'tocilizumab' named entity 'immunomodulatory treatment' named entity 'interstitial pneumonia' named entity 'hemoperfusion' named entity 'SARS-COV-2' named entity 'systemic inflammation' named entity 'sorbent' named entity 'organ failure' named entity 'virus' named entity 'tocilizumab' named entity 'SARS-CoV-2' named entity 'SARS-COV-2' named entity 'molecular weight' named entity 'kDa' named entity 'acute-phase reactant' named entity 'tumor cells' named entity 'CytoSorbents' named entity 'cytokine release syndrome' named entity 'prone position' named entity 'ARDS' named entity 'pneumonia' named entity 'tocilizumab' named entity 'PaO2' named entity 'SARS-COV-2' named entity 'inflammation' named entity 'inflammatory mediators' named entity 'ICU' named entity 'H1N1' named entity 'inflammatory mediators' named entity 'lopinavir/ritonavir' named entity 'hemophagocytic syndrome' named entity 'lumen' named entity 'polystyrene' named entity 'lopinavir/ritonavir' named entity 'germs' named entity 'inflammatory mediators' named entity 'tocilizumab' named entity 'SARS-COV-2' named entity 'IL-6' named entity 'tocilizumab' named entity 'inflammatory mediators' named entity 'tocilizumab' named entity 'inflammatory mediators' named entity 'mechanical ventilation' named entity 'Anti-IL-6' named entity 'anticoagulation' named entity 'SARS-COV-2' named entity 'A.T.' named entity 'anti-IL-6' named entity 'bone marrow aspirate' named entity 'interleukin' named entity 'endothelial' named entity 'SARS-COV-2' named entity 'pharyngeal' named entity 'IL-6' named entity 'septic shock' named entity 'FIO2' named entity 'IL-6' named entity 'copolymer' named entity 'IL-6' named entity 'receptor' named entity 'FIO2' named entity 'free of symptoms' named entity 'coronavirus disease' named entity 'anti-IL-6' named entity 'IL-2' named entity 'chimeric antigen' named entity 'septic shock' named entity 'bronchoalveolar lavage' named entity 'IL-6' named entity 'T-cells' named entity 'cytokine' named entity 'inflammatory' named entity 'viruses' named entity 'C-reactive protein' named entity 'CRP' named entity 'tocilizumab'

Attributes

Values

Creator

Berlot, Giorgio
Amato, Paola
Bianco, Francesco
Chiella, Fabrizio
Gerini, Ugo
La Fata, Cristina
Piva, Marco
Randino, Anna
Roman Pognuz, Erik
Tomasini, Ariella
Tomietto, Paola
Trenti, Tommaso
di Maso, Vittorio

is schema:about of

named entity 'Case'
named entity 'Pneumonia'
named entity 'Tocilizumab'
named entity 'Pneumonia'
named entity 'SARS-COV-2'
named entity 'Italy'
named entity 'Monmouth Junction'
named entity 'sepsis'
named entity 'chimeric antibody'
named entity 'rheumatoid arthritis'
named entity 'tocilizumab'
named entity 'immunomodulatory treatment'
named entity 'interstitial pneumonia'
named entity 'hemoperfusion'
named entity 'SARS-COV-2'
named entity 'systemic inflammation'
named entity 'sorbent'
named entity 'organ failure'
named entity 'virus'
named entity 'tocilizumab'
named entity 'SARS-CoV-2'
named entity 'SARS-COV-2'
named entity 'molecular weight'
named entity 'kDa'
named entity 'acute-phase reactant'
named entity 'tumor cells'
named entity 'CytoSorbents'
named entity 'cytokine release syndrome'
named entity 'prone position'
named entity 'ARDS'
named entity 'pneumonia'
named entity 'tocilizumab'
named entity 'PaO2'
named entity 'SARS-COV-2'
named entity 'inflammation'
named entity 'inflammatory mediators'
named entity 'ICU'
named entity 'H1N1'
named entity 'inflammatory mediators'
named entity 'lopinavir/ritonavir'
named entity 'hemophagocytic syndrome'
named entity 'lumen'
named entity 'polystyrene'
named entity 'lopinavir/ritonavir'
named entity 'germs'
named entity 'inflammatory mediators'
named entity 'tocilizumab'
named entity 'SARS-COV-2'
named entity 'IL-6'
named entity 'tocilizumab'
named entity 'inflammatory mediators'
named entity 'tocilizumab'
named entity 'inflammatory mediators'
named entity 'mechanical ventilation'
named entity 'Anti-IL-6'
named entity 'anticoagulation'
named entity 'SARS-COV-2'
named entity 'A.T.'
named entity 'anti-IL-6'
named entity 'bone marrow aspirate'
named entity 'interleukin'
named entity 'endothelial'
named entity 'SARS-COV-2'
named entity 'pharyngeal'
named entity 'IL-6'
named entity 'septic shock'
named entity 'FIO2'
named entity 'IL-6'
named entity 'copolymer'
named entity 'IL-6'
named entity 'receptor'
named entity 'FIO2'
named entity 'free of symptoms'
named entity 'coronavirus disease'
named entity 'anti-IL-6'
named entity 'IL-2'
named entity 'chimeric antigen'
named entity 'septic shock'
named entity 'bronchoalveolar lavage'
named entity 'IL-6'
named entity 'T-cells'
named entity 'cytokine'
named entity 'inflammatory'
named entity 'viruses'
named entity 'C-reactive protein'
named entity 'CRP'
named entity 'tocilizumab'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software